Elevation Oncology Inc
NASDAQ:ELEV
Elevation Oncology Inc
NASDAQ:ELEV
Price:
0.365
USD
-2.12%
Market Closed
Market Cap:
$21.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Elevation Oncology Inc
NASDAQ:ELEV
|
US |
|
Motorcar Parts of America Inc
NASDAQ:MPAA
|
US |
|
D
|
Diamond Building Products PCL
SET:DRT
|
TH |
|
H
|
Hydrogene De France SA
PAR:HDF
|
FR |
|
Freehold Royalties Ltd
TSX:FRU
|
CA |
|
Inner Mongolia Dian Tou Energy Corp Ltd
SZSE:002128
|
CN |
|
SM Energy Co
NYSE:SM
|
US |
|
S
|
Sky ICT PCL
SET:SKY
|
TH |
|
Y
|
Yorkey Optical International (Cayman) Ltd
HKEX:2788
|
HK |
|
Aisin Corp
OTC:ASEKY
|
JP |
|
Arm Holdings PLC
NASDAQ:ARM
|
UK |
Income Statement
Earnings Waterfall
Elevation Oncology Inc
Elevation Oncology Inc
Income Statement
Elevation Oncology Inc
Elevation Oncology Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(17)
|
(20)
|
(22)
|
(31)
|
(32)
|
(44)
|
(59)
|
(86)
|
(95)
|
(89)
|
(79)
|
(51)
|
(40)
|
(39)
|
(40)
|
(42)
|
(45)
|
(46)
|
|
| Selling, General & Administrative |
(2)
|
(2)
|
(3)
|
(6)
|
(8)
|
(11)
|
(14)
|
(15)
|
(16)
|
(16)
|
(16)
|
(16)
|
(15)
|
(14)
|
(15)
|
(15)
|
(16)
|
(16)
|
|
| Research & Development |
(15)
|
(18)
|
(19)
|
(26)
|
(24)
|
(33)
|
(45)
|
(70)
|
(79)
|
(72)
|
(62)
|
(35)
|
(25)
|
(24)
|
(25)
|
(27)
|
(29)
|
(29)
|
|
| Operating Income |
(17)
N/A
|
(20)
-18%
|
(22)
-8%
|
(31)
-42%
|
(32)
-2%
|
(44)
-38%
|
(59)
-34%
|
(86)
-44%
|
(95)
-10%
|
(89)
+6%
|
(79)
+12%
|
(51)
+35%
|
(40)
+21%
|
(39)
+4%
|
(40)
-3%
|
(42)
-6%
|
(45)
-6%
|
(46)
-2%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(3)
|
(2)
|
(0)
|
1
|
1
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(5)
|
(5)
|
(5)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
|
| Total Other Income |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
4
|
3
|
3
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(17)
N/A
|
(20)
-18%
|
(22)
-8%
|
(31)
-42%
|
(32)
-2%
|
(44)
-38%
|
(59)
-34%
|
(86)
-45%
|
(95)
-11%
|
(95)
+0%
|
(85)
+10%
|
(57)
+33%
|
(46)
+20%
|
(39)
+14%
|
(40)
-1%
|
(42)
-6%
|
(44)
-6%
|
(48)
-8%
|
|
| Net Income | |||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(17)
|
(20)
|
(22)
|
(31)
|
(32)
|
(44)
|
(59)
|
(86)
|
(95)
|
(95)
|
(85)
|
(57)
|
(46)
|
(39)
|
(40)
|
(42)
|
(44)
|
(48)
|
|
| Net Income (Common) |
(17)
N/A
|
(20)
-18%
|
(22)
-8%
|
(31)
-42%
|
(32)
-2%
|
(44)
-38%
|
(59)
-34%
|
(86)
-45%
|
(95)
-11%
|
(95)
+0%
|
(85)
+10%
|
(57)
+33%
|
(46)
+20%
|
(39)
+14%
|
(40)
-1%
|
(42)
-6%
|
(44)
-6%
|
(48)
-8%
|
|
| EPS (Diluted) |
-0.76
N/A
|
-0.89
-17%
|
-0.96
-8%
|
-1.36
-42%
|
-2.64
-94%
|
-1.9
+28%
|
-2.54
-34%
|
-3.67
-44%
|
-4.09
-11%
|
-4.01
+2%
|
-3.08
+23%
|
-1.34
+56%
|
-1.34
N/A
|
-0.83
+38%
|
-0.67
+19%
|
-0.7
-4%
|
-0.78
-11%
|
-0.81
-4%
|
|
Switch to:
Switch to:
See Also
Discover More
